Onkologijos klinika - Company finances
|
EUR
|
2023
From: 2023-03-08
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 9,377 | 376,073 | 393,861 |
| Profit before tax | -54,838 | -50,239 | -93,914 |
| Net profit | -54,838 | -50,239 | -93,914 |
| Equity | -52,338 | -102,577 | -64,491 |
| Liabilities | 209,610 | 247,019 | 174,685 |
| Non-current assets | 145,044 | 105,100 | 92,743 |
| Current assets | 12,180 | 39,148 | 15,835 |
| Total assets | 157,224 | 144,248 | 108,578 |
|
Taxes paid
|
|||
| STI taxes | 354 | 9,234 | 37,706 |
| Social insurance contributions | 911 | 30,020 | 41,088 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +3910.6% | +4.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -34.9% | -34.8% | -86.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -584.8% | -13.4% | -23.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -584.8% | -13.4% | -23.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,683 | 12,712 | 10,815 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Onkologijos klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-10-16 | 2024-10-20 | 130.36 |
| 2024-05-16 | 2024-05-16 | 11.47 |
| 2024-01-16 | 2024-02-13 | 0.09 |
Onkologijos klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-01 | 2026-06-02 | 35.75 |
| 2026-05-31 | 2026-05-31 | 32.23 |
| 2026-05-26 | 2026-05-30 | 0.2 |
| 2026-05-25 | 2026-05-25 | 682.2 |
| 2026-05-22 | 2026-05-24 | 0.2 |
| 2026-05-19 | 2026-05-21 | 170.84 |
| 2026-05-14 | 2026-05-18 | 170.64 |
| 2026-05-12 | 2026-05-13 | 157.0 |
| 2026-03-13 | 2026-03-16 | 1022.04 |
| 2025-11-14 | 2025-11-14 | 2017.22 |
| 2025-05-13 | 2025-05-13 | 1925.7 |
| 2025-03-10 | 2025-03-10 | 1903.14 |
| 2025-02-03 | 2025-02-10 | 229.1 |
| 2024-10-15 | 2024-10-16 | 77.37 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Onkologijos klinika, UAB (code 306269697) is a Private Limited Liability Company operating in specialised hospital services. In 2025, revenue increased to €393.9K from €376.1K in 2024, but the company still posted a net loss of €93.9K, compared with a loss of €50.2K a year earlier. The profit margin remained negative at -23.8%, reflecting continued pressure on profitability despite modest year-on-year revenue growth. Over the 2023–2025 period, revenue expanded sharply from a very small base in 2023 to nearly €394K in 2025, while losses persisted throughout. The balance sheet weakened in 2025: total assets fell to €108.6K from €144.2K in 2024, equity stayed negative at -€64.5K, and liabilities declined to €174.7K. Long-term assets amounted to €92.7K and short-term assets to €15.8K. Asset turnover was 3.63x, indicating relatively efficient use of assets, while ROA was -86.5%; ROE is not meaningfully interpretable because equity remained negative. Revenue per employee was €10.9K, with profit per employee at -€2.6K.